Concepedia

Publication | Open Access

Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma

533

Citations

24

References

2019

Year

Abstract

ClinicalTrials.gov identifier: NCT02657889.

References

YearCitations

Page 1